BioReference Laboratories Meet Ravgen, the Little-Known Company Rattling NIPTs Biggest Players in Court Premium The firm alleges its competitors infringe its patents describing processes for finding chromosomal abnormalities in fetal cell-free DNA. Opko Health Q3 Revenues Fall 10 Percent Despite decreases in COVID-19 testing volume, the firm saw an increase in clinical and genomic test revenue. BioReference Labs Acquires US Ariosa Lab NIPT Business From Roche The business will complement BioReference's specialty health division GenPath, which offers a noninvasive prenatal screening test. Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent The firm saw increases in SARS-CoV-2, clinical, and genomic testing and processed approximately 2.8 million COVID-19 PCR tests. Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand The company reported revenues of $545.2 million compared to $211.5 million in the year-ago quarter, primarily driven by COVID-19 testing. Apr 1, 2021 BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB Feb 18, 2021 Opko Health Q4 Revenues More Than Double Thanks to COVID-19 Testing Dec 20, 2020 How Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19? Premium Oct 30, 2020 Opko Health Q3 Revenues Up 87 Percent Aug 12, 2020 GeneDx Inks Neonatal Genomic Services Deal With Pediatrix Medical Group Mar 14, 2020 Trump Administration Highlights Role of Private Sector in Effort to Increase Coronavirus Testing Mar 13, 2020 BioReference Partners With NY State to Provide Drive-Through SARS-CoV-2 Testing Mar 5, 2020 Commercial Labs Step up Coronavirus Test Efforts After FDA Guidance Dec 6, 2019 Local Coverage Determinations Roundup: Transplant Genomics, Opko Health Apr 3, 2019 NIPT Laboratories Don't Follow All ACMG Recommendations for Reporting, Patient Education Aug 28, 2018 BioReference Labs' GenPath to Participate in NCI-MATCH Jun 22, 2018 Some Stakeholders Not on Board With Draft Bill on New Dx Regulatory Framework Premium Jan 12, 2018 GeneDx, Radboud UMC Collaborate on Research Into Neurodevelopmental Disorders Nov 22, 2017 Longstanding Genetic Testing Website GeneTests Closing Sep 19, 2017 BioReference, The Garage Form Alliance to Advance Patient Care Jun 7, 2017 UC Health to Have Expanded Access to GeneDx Tests Apr 24, 2017 Diaceutics Inks Deal for BioReference Labs Dx Data Jan 10, 2017 Natera Terminates Bio-Reference Labs NIPT Distribution Agreement Jan 4, 2017 Genetic Testing Firms Establish NIPT Advocacy Organization Jan 4, 2017 Natera Files Suit Against Bio-Reference Laboratories for Breach of Contract Load More Breaking News NanoString, A*Star, Next Level Genomics to Launch Spatial Biology Laboratory in Singapore FDA Approves Entrogen's RAS Mutation Detection Kit as CDx for Vectibix Cancer Predisposition Variants Increase Secondary Cancer Mortality Risk in Pediatric Survivors BostonGene, Johns Hopkins University Partner for Multiple Cancer Clinical Research Projects KromaTid, Noble Life Sciences Ink Distribution, OEM Agreement The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.